TrialBMJ open2019

Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials.

Joseline Guetsop Zafack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.